Event Date/Time: Apr 26, 2004
End Date/Time: Apr 27, 2004
Despite intensive ongoing investment in technologies to support preclinical research, the attrition rate in drug discovery continues to be a real problem for the pharma industry. This conference will be examining how tools for preclinical development are being developed and implemented today, focusing specifically on predictive modeling and compound selection. The impressive group of experts working in the field of predictive tools and modeling, include speakers from: Pfizer Global R&D, AstraZeneca, NV Organon, Novartis Pharma AG, Aventis Pharma AG, F. Hoffmann-La Roche, Schering AG, and many other key industry players.